Aim: To assess the incidence and associated signs and symptoms of patients with keratoconus in Asir Province, Saudi Arabia. Methods: 125 new keratoconus patients (51 male, 74 female; mean age 18.5 (SD 3.8) years; range 8-28 years) were recruited from referrals to the department of ophthalmology, Asir Central Hospital, over a 1 year period. Age, visual acuity, and keratometry were recorded along with clinical signs and symptoms.
K eratoconus is a non-inflammatory, acquired ectasia that causes progressive, changeable, myopic astigmatism. Mostly it occurs bilaterally but develops asymmetrically, 1 with an onset at puberty and progression over a period of 7-20 years. 2 3 Incidence ranges from 1.4 to 600 cases per year per 100 000 population. [4] [5] [6] [7] [8] [9] Most reports have considered white populations, with some studies suggesting an influence of ethnic origin on the incidence and age at onset. 10 11 Previous studies on keratoconus in Saudi Arabia are very limited. 12 13 This paper reports a prospective study that assesses the incidence rate and associated signs and symptoms of patients with keratoconus in Asir Province, Saudi Arabia.
METHODS
All patients attending the department of ophthalmology, Asir Central Hospital, Saudi Arabia, between May 2001 and April 2002, who were suspected of having keratoconus, were recruited, as were patients newly diagnosed with keratoconus but attending other tertiary hospitals in Asir Province. In total, 125 patients (240 eyes) were recruited, comprising 51 males and 74 females (mean age 18.5 (SD 3.9) years; range 8-28 years). All subjects were examined for case history, visual acuity, keratometry, refraction, and ocular signs. Diagnosis was made on the basis of changes in best corrected visual acuity, familial keratoconus, an irregular surface evidenced by distorted corneal curvature, keratometry, scissoring of the retinoscopic reflex, or irregularity in the red reflex on direct ophthalmoscopy. Clinical signs included at least one of the following: central corneal thinning, apical stromal scaring, Vogt's striae, Fleischer's ring, and Munson's sign. Unusual cases for which a diagnosis could not be established with confidence were excluded. All data were analysed using the statistical software package SPSS 12 (SPSS Inc, USA).
RESULTS
The incidence of keratoconus in Asir Province was calculated using the area population for those aged between 5 and 29 years (654 163), 14 because the disease usually develops within this age range, and because the study's age range was also of this order (8-28 years) . With this calculation, the incidence was 20 cases per 100 000. Mean age at diagnosis was 17.7 (3.6) years for males (range 8-24 years) and 19.0 (3.8) years for females (range 12-28 years) (fig 1) .
Visual acuity measurements indicated that uncorrected vision decreased with increasing disease severity and was classified on the basis of average keratometry reading (table 1) . As corneal astigmatism and curvature increased vision decreased. However, visual acuity (VA) values were variable even for patients at the same disease stage. The data also show that the overall steepening of the cornea produces a greater change in VA than does any increase in astigmatism (fig 2) .
Depending on the stage of the disease, VA was improvable for 108 eyes with spectacles, and 132 eyes with rigid contact lenses (table 2) . With spectacles, 33% of eyes achieved a corrected VA of 6/6 or better, with 100% achieving 6/12 or better. With rigid contact lenses, 93% of eyes achieved 6/6 or better, and 97% 6/12 or better.
The severity of keratoconus was assessed from keratometry reading, in the worse affected eye, and patients' age at diagnosis. 15 16 Based on the keratometry results, the keratoconus population was divided into three groups: early (48D, moderate 48-54D, and advanced .54D (fig 3) .
Twenty of 125 (16%) patients had eczema, asthma, and/or vitiligo. Another 20 patients had a family history of keratoconus. There was no evidence of tapeto-retinal degeneration or Reiger's anomaly. Further, we encountered no systemic diseases such as Down's, Marfan's or EhlersDanlos syndromes. Seventy of 125 (56%) patients had a positive ocular history for one or more of the following keratoconus associated factors: eye rubbing, ocular allergy, tearing, ocular redness, or vernal keratoconjunctivitis (fig 4) . Five patients between the ages of 6 and 12 years reported all five symptoms, and three of these also had a family history of keratoconus.
DISCUSSION
The ability to describe the incidence of a disease is important for predicting current and future clinical needs, and for establishing disease characteristics in a particular population. This study found an incidence of keratoconus in Asir Province, Saudi Arabia, to be 20 per 100 000 based on referrals to the provincial, tertiary level specialist clinic. This compares with 1 per 100 000 in the United Kingdom, 7 2 per 100 000 in Minnesota (USA), 4 2.2 per 100 000 in Finland, 5 2.5 per 100 000 in Holland, 8 and 50 per 100 000 in New Zealand. 6 The incidence of keratoconus in our cohort is comparable to that of 20-25 per 100 000 in Asian populations living in the United Kingdom but higher than for British white people. 10 11 Environmental influences for these groups will presumably be similar and the higher number of consanguineous marriages among Muslims has been proposed as a cause of the increased incidence. 10 11 Previous reported incidences for a family history of keratoconus in white populations are 6%, 17 8.8%, 18 and 23.5%, 19 compared to 16% in this study. In one family reported here, of seven children, four had keratoconus in at least one eye. We should consider the possibility that environmental or geographical factors may have contributed to the incidence and severity of keratoconus found in this study. Asir Province is a mountainous region and the majority of patients in our study (95%) live at an altitude of 3000 metres on average. Here, people are likely have a greater exposure to ultraviolet, given that levels increase with altitude by approximately 10% for every 1000 metres of elevation. 20 Ultraviolet light has previously been linked to keratoconus. Some investigators have proposed that keratoconic corneas have underlying defects in their ability to process accumulated reactive oxygen species, and that this might have a role in the disease pathogenesis. 21 22 The effect of ultraviolet light has also been used to explain the high incidence of keratoconus in New Zealand, which has a white population similar to the United Kingdom, but, because the ozone layer is thinner, a greater ultraviolet background. 19 This link, however, could not be proved definitively since it was not possible to assess actual ultraviolet dosage. Thus, the role of ultraviolet requires further study before it can be determined as a risk factor for keratoconus in patients from Asir Province, Saudi Arabia.
An early age of onset was recorded in this study (18.5 years) with approximately three quarters of our patients (74.4%) presenting before the age of 20 years (in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) study only 4% presented by this time 17 ). Investigations in white populations have reported a higher age at the time of study (mean 27 years) suggesting a later disease onset. 4 23 VA decreases as corneal curvature and astigmatism increase (fig 2) . However, the correlations are not strong because of the variable influence of the amount, regularity, and obliqueness of the astigmatism, the level of progressive myopia, the scar type, morphology of the cone, and extent of any atopic disease. This indicates that the VA of a keratoconus patient does not present an accurate picture of the progress of the disease. Clinically this is seen when a keratoconic patient presents with an equal bilateral stage of the disease, with a VA in each eye that is manifestly different. Contact lenses generally provided the best means of improving vision, with 93% of eyes achieving 6/6 or better. Only one third of spectacle wearers achieved this level.
Atopic diseases (asthma and atopic dermatitis) have been suggested as aetiological components of keratoconus. Here, we did not find a strong pattern of association with only 16% of our patients reporting any form of atopy. This compares with an average of 35% reported by others. 26 27 A link between allergy and eye rubbing has been reported, 28 with atopic patients thought to develop keratoconus as a result of eye rubbing. 29 Karsersas and Ruben, 30 for example, found a history of eye rubbing in 66% of their keratoconus patients, while Weed and McGhee 31 indicated that 48% of keratoconus patients rubbed their eyes. In the current study, 49 (39.2%) and 56 (44.8%) patients complained of allergy and rubbing, respectively. In addition, 15 of 30 (50%) patients in the early stage, 32 of 59 (54%) patients in the moderate stage, and 23 of 36 (63.8%) patients in the advanced stage complained of both allergy and rubbing.
In conclusion, an early onset and increased severity of keratoconus was found in Asir Province, Saudi Arabia. This may be related to a combination of genetic and/or environmental factors. Clinically, contact lens correction should be considered earlier to maximise visual performance. The results have implications for keratoconus screening in Saudi Arabia, to improve early detection and treatment.
The work was done in accordance with the ethical rules of the Saudi Ministry of Health and Asir Central Hospital. none was associated with CLL or CTCL. Some pigmentary changes were described in these cases, but in a pattern quite different from that seen in our patients.
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To date of approximately 6000 patients treated with denileukin diftitox the manufacturer has only nine reports of visual disturbance including these patients (data on file at Ligand Pharmaceuticals). Formal review of these reports has not revealed a clear pattern of ocular involvement. However, the similarity of the two cases reported here is striking, and raises the possibility of a novel toxic retinopathy.
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